Zyprexa, Zydis, Olanzapine News

“Therefore, new therapies that are both effective and well-tolerated would be welcome additions to the treatment options currently available for improving patient care.”

Efficacy and safety data support potential of asenapine in the treatment of schizophrenia and bipolar I disorder WASHINGTON, May 8 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced that an ... via Earth Times

Comment?

A new research effort investigates the medical side-effects of new or second generation(Zyprexa) antipsychotic medications prescribed for schizophrenia.

7 comments

By ALEX BERENSON March 26, 2008 Eli Lilly has agreed to pay $15 million to the state of Alaska to settle a lawsuit claiming that the company's schizophrenia drug Zyprexa caused patients to develop diabetes, ...

1 comment

Attorney General Richard Blumenthal today sued Eli Lilly and Company, Inc. for illegally marketing its antipsychotic drug Zyprexa for unapproved uses, and concealing the drug's serious side effects, for more ...

4 comments

Connecticut has become the latest US state to sue Eli Lilly after claiming that the firm marketed the antipsychotic Zyprexa for unapproved off-label uses,and hid side effects such as weight gain and diabetes.

2 comments

Eli Lilly , the drug maker, could and should have warned physicians as early as 1998 about the link between Zyprexa, its best-selling schizophrenia medicine, and diabetes , an expert witness told jurors Friday ...

4 comments

Eli Lilly has faced legal problems over evidence that Zyprexa, a top-selling medicine, tends to cause weight gain and diabetes.

Comment?

In a surprise move, the Food and Drug Administration issued a non-approvable letter for the injection because of questions about the "excessive sedation events" seen in patients taking the drug.

5 comments

Eli Lilly has paid more than $1 billion to settle legal battles over its top-selling drug Zyprexa, and it might have to write another large check soon.

8 comments

Newspaper: $1B payment would settle probe into marketing of Zyprexa ...

2 comments